The pCONUS HPC: 30-Day and 180-Day In Vivo Biocompatibility Results

Background Endovascular stents are commonly used during neurointerventional procedures; however, the concomitant use of dual anti-platelet treatment (DAPT) can limit their use. There is a need to develop stent coatings that mitigate requirement for DAPT.